Qiuyan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qiuyan Chen has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- John Joseph Grubb Tesmer
Department of Biological Sciences, Purdue University, West Lafayette, IN
3 shared publications Katelyn Tepper
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
3 shared publicationsYa Zhuo
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA
3 shared publications- Adriano Marchese
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA
2 shared publications - Anthony A. Kossiakoff
Department of Biochemistry and Molecular Biology, University of Chicago , Chicago, IL 60637
2 shared publications - Candice S. Klug
Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
2 shared publications
Latest Publications
- Open Access
Cooperative Control of Arrestin Activation By Membrane Lipids And Phosphorylation Barcodes
Arrestins regulate G protein–coupled receptor (GPCR) signaling by binding phosphorylated receptors embedded in lipid bilayers, yet how receptor phosphorylation and membrane composition cooperate to control arrestin activation remains unclear. Here, we reconstitute this interplay using N-terminally palmitoylated phosphopeptides tethered to nanodiscs of defined lipid composition and quantitatively measure arrestin-2 (Arr2) activation and membrane engagement. We find that both receptor phosphorylation and the lipid environment are essential for robust Arr2 activation, with phosphoinositides (PIPs) and other anionic lipids facilitating Arr2 activation and membrane association through distinct mechanisms. Systematic profiling of phosphorylation barcodes derived from atypical chemokine receptor 3 (ACKR3) and vasopressin receptor 2 (V 2 R) identifies phospho-motifs that potently activate Arr2. Moreover, the position of these motifs relative to the membrane determines Arr2 engagement, supporting a model of regional phosphorylation barcodes. Genome-wide motif analysis further links the phosphorylation barcode to predicted arrestin coupling strength and classification into Class A or Class B GPCRs. Finally, lipidated phosphopeptides inhibit GPCR–Arr2 interactions in live cells and enable structural characterization of Arr2–phosphopeptide complexes by cryo-electron microscopy, establishing a membrane-integrated framework for decoding arrestin response.
Open AccessCooperative Control of Arrestin Activation By Membrane Lipids And Phosphorylation Barcodes
Arrestins regulate G protein–coupled receptor (GPCR) signaling by binding phosphorylated receptors embedded in lipid bilayers, yet how receptor phosphorylation and membrane composition cooperate to control arrestin activation remains unclear. Here, we reconstitute this interplay using N-terminally palmitoylated phosphopeptides tethered to nanodiscs of defined lipid composition and quantitatively measure arrestin-2 (Arr2) activation and membrane engagement. We find that both receptor phosphorylation and the lipid environment are essential for robust Arr2 activation, with phosphoinositides (PIPs) and other anionic lipids facilitating Arr2 activation and membrane association through distinct mechanisms. Systematic profiling of phosphorylation barcodes derived from atypical chemokine receptor 3 (ACKR3) and vasopressin receptor 2 (V 2 R) identifies phospho-motifs that potently activate Arr2. Moreover, the position of these motifs relative to the membrane determines Arr2 engagement, supporting a model of regional phosphorylation barcodes. Genome-wide motif analysis further links the phosphorylation barcode to predicted arrestin coupling strength and classification into Class A or Class B GPCRs. Finally, lipidated phosphopeptides inhibit GPCR–Arr2 interactions in live cells and enable structural characterization of Arr2–phosphopeptide complexes by cryo-electron microscopy, establishing a membrane-integrated framework for decoding arrestin response.
- Open Access
- 7 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Distinct membrane binding properties of the two non-visual arrestins
Membrane interactions play a crucial role in regulating arrestin activation and its binding to phosphorylated G protein-coupled receptors (GPCRs). Here, we combine in vitro biophysical approaches with cell-based fluorescence intensity fluctuation analysis to systematically compare the membrane-binding properties of the two highly conserved non-visual arrestin subtypes, arrestin-2 and arrestin-3. We find that in the absence of stimulation, arrestin-2 primarily engages PI(4,5)P2-enriched membranes through its C-edge and exhibits higher affinity than arrestin-3. When activated, arrestin-2, but not arrestin-3, predominantly shifts to using its finger loop to engage PI(4,5)P2-containing nanodiscs. Notably, while the lipid bilayer alone does not fully activate arrestin, it synergistically promotes arrestin-2/3 recruitment and enhances arrestin-2/3 activation in the presence of a phosphorylated GPCR C-tail. Live-cell tracking further reveals distinct plasma membrane interaction dynamics for arrestin-2 and arrestin-3 upon M2 muscarinic acetylcholine receptor stimulation. Together, these findings uncover new mechanistic insights into arrestin activation and its functional interplay with membranes.
- 7 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessDistinct membrane binding properties of the two non-visual arrestins
Membrane interactions play a crucial role in regulating arrestin activation and its binding to phosphorylated G protein-coupled receptors (GPCRs). Here, we combine in vitro biophysical approaches with cell-based fluorescence intensity fluctuation analysis to systematically compare the membrane-binding properties of the two highly conserved non-visual arrestin subtypes, arrestin-2 and arrestin-3. We find that in the absence of stimulation, arrestin-2 primarily engages PI(4,5)P2-enriched membranes through its C-edge and exhibits higher affinity than arrestin-3. When activated, arrestin-2, but not arrestin-3, predominantly shifts to using its finger loop to engage PI(4,5)P2-containing nanodiscs. Notably, while the lipid bilayer alone does not fully activate arrestin, it synergistically promotes arrestin-2/3 recruitment and enhances arrestin-2/3 activation in the presence of a phosphorylated GPCR C-tail. Live-cell tracking further reveals distinct plasma membrane interaction dynamics for arrestin-2 and arrestin-3 upon M2 muscarinic acetylcholine receptor stimulation. Together, these findings uncover new mechanistic insights into arrestin activation and its functional interplay with membranes.
- Top Cited Papers
- 21 May 2025
- Published by Springer Nature in Nature
- Vol. 643 (8070) , 280-287
Effect of phosphorylation barcodes on arrestin binding to a chemokine receptor
Unique phosphorylation 'barcodes' installed in different regions of an active seven-transmembrane receptor by different G-protein-coupled receptor (GPCR) kinases (GRKs) have been proposed to promote distinct cellular outcomes1, but it is unclear whether or how arrestins differentially engage these barcodes. Here, to address this, we developed an antigen-binding fragment (Fab7) that recognizes both active arrestin2 (β-arrestin1) and arrestin3 (β-arrestin2) without interacting with bound receptor polypeptides. We used Fab7 to determine the structures of both arrestins in complex with atypical chemokine receptor 3 (ACKR3) phosphorylated in different regions of its C-terminal tail by either GRK2 or GRK5 (ref. 2). The GRK2-phosphorylated ACKR3 resulted in more heterogeneous 'tail-mode' assemblies, whereas phosphorylation by GRK5 resulted in more rigid 'ACKR3-adjacent' assemblies. Unexpectedly, the finger loops of both arrestins engaged the micelle surface rather than the receptor intracellular pocket, with arrestin3 being more dynamic, partly because of its lack of a membrane-anchoring motif. Thus, both the region of the barcode and the arrestin isoform involved can alter the structure and dynamics of GPCR-arrestin complexes, providing a possible mechanistic basis for unique downstream cellular effects, such as the efficiency of chemokine scavenging and the robustness of arrestin binding in ACKR3.
- 21 May 2025
- Published by Springer Nature in Nature
- Vol. 643 (8070) , 280-287
Top Cited PapersEffect of phosphorylation barcodes on arrestin binding to a chemokine receptor
Unique phosphorylation 'barcodes' installed in different regions of an active seven-transmembrane receptor by different G-protein-coupled receptor (GPCR) kinases (GRKs) have been proposed to promote distinct cellular outcomes1, but it is unclear whether or how arrestins differentially engage these barcodes. Here, to address this, we developed an antigen-binding fragment (Fab7) that recognizes both active arrestin2 (β-arrestin1) and arrestin3 (β-arrestin2) without interacting with bound receptor polypeptides. We used Fab7 to determine the structures of both arrestins in complex with atypical chemokine receptor 3 (ACKR3) phosphorylated in different regions of its C-terminal tail by either GRK2 or GRK5 (ref. 2). The GRK2-phosphorylated ACKR3 resulted in more heterogeneous 'tail-mode' assemblies, whereas phosphorylation by GRK5 resulted in more rigid 'ACKR3-adjacent' assemblies. Unexpectedly, the finger loops of both arrestins engaged the micelle surface rather than the receptor intracellular pocket, with arrestin3 being more dynamic, partly because of its lack of a membrane-anchoring motif. Thus, both the region of the barcode and the arrestin isoform involved can alter the structure and dynamics of GPCR-arrestin complexes, providing a possible mechanistic basis for unique downstream cellular effects, such as the efficiency of chemokine scavenging and the robustness of arrestin binding in ACKR3.
- Open Access
Distinct Membrane Binding Properties of the Two Non-visual Arrestins
Membrane interactions play a crucial role in regulating arrestin activation and its binding to phosphorylated G protein-coupled receptors (GPCRs). Here, we utilize in vitro biophysical approaches and cell-based fluorescence intensity fluctuation analysis to systematically compare the membrane-binding properties of the two highly conserved arrestin subtypes, arrestin-2 and arrestin-3, under basal and stimulated conditions. Our findings reveal that arrestin-2 selectively engages the PI(4,5)P 2 -containing nanodiscs via its C-edge, whereas arrestin-3 primarily utilizes its finger loop to interact with negatively charged lipids. Notably, while the lipid bilayer alone does not activate arrestin, it synergistically enhances arrestin-2/3 activation in conjunction with a phosphorylated GPCR C-tail. Additionally, the spacing between receptor phosphorylation sites and the lipid bilayer modulates arrestin−membrane assembly. Live cell tracking further demonstrates that arrestin-2 and arrestin-3 exhibit distinct plasma membrane dissociation dynamics. These findings provide novel insights into the mechanisms governing arrestin activation and its functional interplay with membranes.
Open AccessDistinct Membrane Binding Properties of the Two Non-visual Arrestins
Membrane interactions play a crucial role in regulating arrestin activation and its binding to phosphorylated G protein-coupled receptors (GPCRs). Here, we utilize in vitro biophysical approaches and cell-based fluorescence intensity fluctuation analysis to systematically compare the membrane-binding properties of the two highly conserved arrestin subtypes, arrestin-2 and arrestin-3, under basal and stimulated conditions. Our findings reveal that arrestin-2 selectively engages the PI(4,5)P 2 -containing nanodiscs via its C-edge, whereas arrestin-3 primarily utilizes its finger loop to interact with negatively charged lipids. Notably, while the lipid bilayer alone does not activate arrestin, it synergistically enhances arrestin-2/3 activation in conjunction with a phosphorylated GPCR C-tail. Additionally, the spacing between receptor phosphorylation sites and the lipid bilayer modulates arrestin−membrane assembly. Live cell tracking further demonstrates that arrestin-2 and arrestin-3 exhibit distinct plasma membrane dissociation dynamics. These findings provide novel insights into the mechanisms governing arrestin activation and its functional interplay with membranes.
- Open Access
- 9 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Deciphering the unique mechanism whereby bis-sulfonamido-2-phenylbenzoxazole (PBZ) GroEL/ES inhibitors modulate chaperonin ATPase and client protein folding functions.
We previously reported a series of bis-sulfonamido-2-phenylbenzoxazole (PBZ) inhibitors of GroEL/ES and HSP60/10 chaperonin systems that exhibited potent antibiotic effects against bacteria and Trypanosoma brucei parasites, and chemotherapeutic effects against colorectal cancer cells. However, the mechanisms of action of these inhibitors at the protein level and their relative impact on folding in bacterial versus human cells remained unknown. In this study, cryoEM analyses identified a set of 7-fold symmetrical inhibitor binding sites at the GroEL ring-ring interface (RRI). In addition, LC-MS/MS analyses identified two sets of binding sites at the apical domains and the ATP pockets. These findings, coupled with results from biochemical assays evaluating a small panel of PBZ-based inhibitors, allowed the development of a unique mechanistic model that explains how PBZ binding at the three sites modulates the ATPase and client protein folding functions of E. coli GroEL/ES. Screening of our diversity set of structurally distinct GroEL/ES inhibitors highlighted the unique mechanism of PBZ compounds binding to the RRI and disrupting the intra- and inter-ring allostery governing chaperonin function. We further developed complementary intravital reporter assays to measure the targeting of GroEL/ES in S. aureus bacteria and HSP60/10 in the mitochondria of human embryonic kidney (HEK) 293 cells. Compound screening using these assays support the differential engagement of PBZ analogs with chaperonins in bacteria and/or human cells. Together, these results provide a more detailed molecular basis for the findings from our companion study by Godek et al. that elucidated on-target functions of our lead analog, PBZ1038 (compound 1), against GroEL in E. coli. The inhibition model developed here will be invaluable for interpreting the mechanisms of new inhibitors and generating more potent and selective analogs as antibacterial candidates.
- 9 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDeciphering the unique mechanism whereby bis-sulfonamido-2-phenylbenzoxazole (PBZ) GroEL/ES inhibitors modulate chaperonin ATPase and client protein folding functions.
We previously reported a series of bis-sulfonamido-2-phenylbenzoxazole (PBZ) inhibitors of GroEL/ES and HSP60/10 chaperonin systems that exhibited potent antibiotic effects against bacteria and Trypanosoma brucei parasites, and chemotherapeutic effects against colorectal cancer cells. However, the mechanisms of action of these inhibitors at the protein level and their relative impact on folding in bacterial versus human cells remained unknown. In this study, cryoEM analyses identified a set of 7-fold symmetrical inhibitor binding sites at the GroEL ring-ring interface (RRI). In addition, LC-MS/MS analyses identified two sets of binding sites at the apical domains and the ATP pockets. These findings, coupled with results from biochemical assays evaluating a small panel of PBZ-based inhibitors, allowed the development of a unique mechanistic model that explains how PBZ binding at the three sites modulates the ATPase and client protein folding functions of E. coli GroEL/ES. Screening of our diversity set of structurally distinct GroEL/ES inhibitors highlighted the unique mechanism of PBZ compounds binding to the RRI and disrupting the intra- and inter-ring allostery governing chaperonin function. We further developed complementary intravital reporter assays to measure the targeting of GroEL/ES in S. aureus bacteria and HSP60/10 in the mitochondria of human embryonic kidney (HEK) 293 cells. Compound screening using these assays support the differential engagement of PBZ analogs with chaperonins in bacteria and/or human cells. Together, these results provide a more detailed molecular basis for the findings from our companion study by Godek et al. that elucidated on-target functions of our lead analog, PBZ1038 (compound 1), against GroEL in E. coli. The inhibition model developed here will be invaluable for interpreting the mechanisms of new inhibitors and generating more potent and selective analogs as antibacterial candidates.
- Open Access
ACKR3–arrestin2/3 complexes reveal molecular consequences of GRK-dependent barcoding
SUMMARY: Atypical chemokine receptor 3 (ACKR3, also known as CXCR7) is a scavenger receptor that regulates extracellular levels of the chemokine CXCL12 to maintain responsiveness of its partner, the G protein-coupled receptor (GPCR), CXCR4. ACKR3 is notable because it does not couple to G proteins and instead is completely biased towards arrestins. Our previous studies revealed that GRK2 and GRK5 install distinct distributions of phosphates (or “barcodes”) on the ACKR3 carboxy terminal tail, but how these unique barcodes drive different cellular outcomes is not understood. It is also not known if arrestin2 (Arr2) and 3 (Arr3) bind to these barcodes in distinct ways. Here we report cryo-electron microscopy structures of Arr2 and Arr3 in complex with ACKR3 phosphorylated by either GRK2 or GRK5. Unexpectedly, the finger loops of Arr2 and 3 directly insert into the detergent/membrane instead of the transmembrane core of ACKR3, in contrast to previously reported “core” GPCR–arrestin complexes. The distance between the phosphorylation barcode and the receptor transmembrane core regulates the interaction mode of arrestin, alternating between a tighter complex for GRK5 sites and heterogenous primarily “tail only” complexes for GRK2 sites. Arr2 and 3 bind at different angles relative to the core of ACKR3, likely due to differences in membrane/micelle anchoring at their C-edge loops. Our structural investigations were facilitated by Fab7, a novel Fab that binds both Arr2 and 3 in their activated states irrespective of receptor or phosphorylation status, rendering it a potentially useful tool to aid structure determination of any native GPCR–arrestin complex. The structures provide unprecedented insight into how different phosphorylation barcodes and arrestin isoforms can globally affect the configuration of receptor–arrestin complexes. These differences may promote unique downstream intracellular interactions and cellular responses. Our structures also suggest that the 100% bias of ACKR3 for arrestins is driven by the ability of arrestins, but not G proteins, to bind GRK-phosphorylated ACKR3 even when excluded from the receptor cytoplasmic binding pocket.
Open AccessACKR3–arrestin2/3 complexes reveal molecular consequences of GRK-dependent barcoding
SUMMARY: Atypical chemokine receptor 3 (ACKR3, also known as CXCR7) is a scavenger receptor that regulates extracellular levels of the chemokine CXCL12 to maintain responsiveness of its partner, the G protein-coupled receptor (GPCR), CXCR4. ACKR3 is notable because it does not couple to G proteins and instead is completely biased towards arrestins. Our previous studies revealed that GRK2 and GRK5 install distinct distributions of phosphates (or “barcodes”) on the ACKR3 carboxy terminal tail, but how these unique barcodes drive different cellular outcomes is not understood. It is also not known if arrestin2 (Arr2) and 3 (Arr3) bind to these barcodes in distinct ways. Here we report cryo-electron microscopy structures of Arr2 and Arr3 in complex with ACKR3 phosphorylated by either GRK2 or GRK5. Unexpectedly, the finger loops of Arr2 and 3 directly insert into the detergent/membrane instead of the transmembrane core of ACKR3, in contrast to previously reported “core” GPCR–arrestin complexes. The distance between the phosphorylation barcode and the receptor transmembrane core regulates the interaction mode of arrestin, alternating between a tighter complex for GRK5 sites and heterogenous primarily “tail only” complexes for GRK2 sites. Arr2 and 3 bind at different angles relative to the core of ACKR3, likely due to differences in membrane/micelle anchoring at their C-edge loops. Our structural investigations were facilitated by Fab7, a novel Fab that binds both Arr2 and 3 in their activated states irrespective of receptor or phosphorylation status, rendering it a potentially useful tool to aid structure determination of any native GPCR–arrestin complex. The structures provide unprecedented insight into how different phosphorylation barcodes and arrestin isoforms can globally affect the configuration of receptor–arrestin complexes. These differences may promote unique downstream intracellular interactions and cellular responses. Our structures also suggest that the 100% bias of ACKR3 for arrestins is driven by the ability of arrestins, but not G proteins, to bind GRK-phosphorylated ACKR3 even when excluded from the receptor cytoplasmic binding pocket.
- Open Access
- 4 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8679
Short Arrestin-3-Derived Peptides Activate JNK3 in Cells
Arrestins were first discovered as suppressors of G protein-mediated signaling by G protein-coupled receptors. It was later demonstrated that arrestins also initiate several signaling branches, including mitogen-activated protein kinase cascades. Arrestin-3-dependent activation of the JNK family can be recapitulated with peptide fragments, which are monofunctional elements distilled from this multi-functional arrestin protein. Here, we use maltose-binding protein fusions of arrestin-3-derived peptides to identify arrestin elements that bind kinases of the ASK1-MKK4/7-JNK3 cascade and the shortest peptide facilitating JNK signaling. We identified a 16-residue arrestin-3-derived peptide expressed as a Venus fusion that leads to activation of JNK3α2 in cells. The strength of the binding to the kinases does not correlate with peptide activity. The ASK1-MKK4/7-JNK3 cascade has been implicated in neuronal apoptosis. While inhibitors of MAP kinases exist, short peptides are the first small molecule tools that can activate MAP kinases.
- 4 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8679
Open AccessShort Arrestin-3-Derived Peptides Activate JNK3 in Cells
Arrestins were first discovered as suppressors of G protein-mediated signaling by G protein-coupled receptors. It was later demonstrated that arrestins also initiate several signaling branches, including mitogen-activated protein kinase cascades. Arrestin-3-dependent activation of the JNK family can be recapitulated with peptide fragments, which are monofunctional elements distilled from this multi-functional arrestin protein. Here, we use maltose-binding protein fusions of arrestin-3-derived peptides to identify arrestin elements that bind kinases of the ASK1-MKK4/7-JNK3 cascade and the shortest peptide facilitating JNK signaling. We identified a 16-residue arrestin-3-derived peptide expressed as a Venus fusion that leads to activation of JNK3α2 in cells. The strength of the binding to the kinases does not correlate with peptide activity. The ASK1-MKK4/7-JNK3 cascade has been implicated in neuronal apoptosis. While inhibitors of MAP kinases exist, short peptides are the first small molecule tools that can activate MAP kinases.
- Open Access
- 19 July 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (9) , 102279
G protein–coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias
- 19 July 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (9) , 102279
Open AccessG protein–coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias